Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Envu is a global environmental science leader that provides innovative solutions for pest, weed, and disease control in non-agricultural settings. Formed in 2022 following the acquisition of Bayer’s Environmental Science Professional business by the private equity firm Cinven, the company focuses on protecting public health, hygiene, and the environment. Envu operates across several key markets, including professional pest management, vector control, golf and turf management, and forestry. The company’s portfolio features industry-leading brands such as Maxforce, Suspend, and Esplanade, supported by a strong commitment to sustainable practices and digital innovation. Headquartered in Cary, North Carolina, Envu maintains a significant global footprint with operations in over 100 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Envu.